Company Overview
About Genomelink
Genomelink is a San Francisco-based DNA app store and personalized genomics platform that allows users to upload raw DNA data from Ancestry, 23andMe, or other consumer DNA tests and access a marketplace of analysis apps covering ancestry, traits, health predispositions, and wellness insights. Founded in 2017 and backed by $4.5-9 million from 500 Global, Asymmetry Ventures, and 27 total investors, Genomelink generated $3.3 million in revenue in 2024 with a 22-person team, serving consumers who want more from their raw genetic data than the original testing company provides.
Business Model & Competitive Advantage
Genomelink's platform enables third-party developers to build apps on top of user DNA data through its API and app store model — similar to how the iPhone App Store enables a developer ecosystem, Genomelink enables genomics app developers to reach users who have already paid for sequencing and want additional insights. Users grant permissions for specific apps to access their genetic data, and Genomelink handles the security, privacy, and data processing infrastructure. Apps cover trait prediction (athletic potential, food preferences, sleep chronotype), ancestry analysis beyond what 23andMe or Ancestry provides, and carrier status for genetic conditions.
Competitive Landscape 2025–2026
In 2025, Genomelink competes in the consumer genomics and genetic insights market with Ancestry (the dominant US family history and DNA platform), 23andMe (which filed for bankruptcy protection in 2024, later acquired), and LifeDNA (similar DNA insights marketplace) for consumers seeking personalized genetics insights. 23andMe's bankruptcy creates market opportunity — millions of 23andMe users who want to keep using their existing raw DNA data need alternatives to the 23andMe app, and Genomelink can serve these users by importing their existing raw DNA files. The 2025 strategy focuses on growing the 23andMe user migration opportunity, expanding the developer app ecosystem, and adding health and wellness tracking features that use genetic data to personalize lifestyle recommendations.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Genomelink is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Compare Genomelink with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Genomelink? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Genomelink Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Genomelink vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →